Currently, Professor Malapelle is chairman of the Laboratory of Predictive Molecular Pathology, Department of Public Health, University Federico II. He holds the position of scientific secretary of the International Society of Liquid Biopsy and editor-in-chief of The Journal of Liquid Biopsy. His main research interest is in the field of validation and testing of genomic biomarkers for predictive information in solid tumors, with a focus on lung cancer. In addition, he has developed expertise in tailoring next-generation assays for various applications for simultaneous detection of clinically relevant alterations (e.g., EGFR mutations, ALK translocation, PD-L1 expression) in the routine setting, including the handling of different types of samples, such as tissue and/or liquid biopsy specimens.